- Home
- BGT vs AMRN Comparison
BGT vs AMRN Comparison
Compare BGT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BGT | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.3M | 304.3M |
| IPO Year | 2004 | 1998 |
Fundamental Metrics
Financial Performance| Metric | BGT | AMRN |
|---|---|---|
| Price | $10.97 | $15.12 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 101.7K | 78.2K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $10.22 | $11.03 |
| 52 Week High | $12.76 | $20.90 |
Technical Indicators
Market Signals| Indicator | BGT | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 50.00 | 56.23 |
| Support Level | $10.83 | $14.65 |
| Resistance Level | $11.14 | $15.20 |
| Average True Range (ATR) | 0.08 | 0.67 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 40.32 | 75.95 |
Price Performance
Historical ComparisonAbout BGT BlackRock Floating Rate Income Trust
Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.